Literature DB >> 7491518

Laparoscopic detection of hepatic metastases in patients with residual or recurrent medullary thyroid cancer.

W S Tung1, T M Vesely, J F Moley.   

Abstract

BACKGROUND: After initial operations for medullary thyroid cancer (MTC), reoperation with removal of metastatic disease confined to the neck may benefit some patients. The identification of distant metastases precludes the possibility of curative reoperation.
METHODS: Forty-one patients with hypercalcitoninemia after initial surgical treatment for MTC underwent laparoscopic (n = 36) or open (n = 5) examination and biopsy of the liver. Thirty-seven of these patients underwent imaging by computed tomography (CT), magnetic resonance imaging (MRI) of the liver, or both, and 17 underwent selective venous catheterization (SVC) with measurement of hepatic and peripheral vein stimulated calcitonin levels.
RESULTS: Liver metastases were found in eight patients, seven by laparoscopy and one by open examination. Seven of these patients had normal CT or MRI scans of the liver. Laparoscopy or open liver examination revealed metastases in 2 of 11 patients with elevated hepatic vein-peripheral vein stimulated calcitonin ratios (greater than 1.3). Metastases appeared as small (less than 5 mm), bright white nodules on the surface of the liver.
CONCLUSIONS: Direct examination and biopsy of the liver by laparoscopy may show small deposits of metastatic MTC in patients with normal CT and MRI scanning.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7491518     DOI: 10.1016/s0039-6060(05)80109-6

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  16 in total

Review 1.  Thyroid cancer surgery.

Authors:  R Udelsman
Journal:  Rev Endocr Metab Disord       Date:  2000-04       Impact factor: 6.514

Review 2.  Medullary thyroid cancer: monitoring and therapy.

Authors:  Douglas W Ball
Journal:  Endocrinol Metab Clin North Am       Date:  2007-09       Impact factor: 4.741

Review 3.  Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.

Authors:  Samuel A Wells; Sylvia L Asa; Henning Dralle; Rossella Elisei; Douglas B Evans; Robert F Gagel; Nancy Lee; Andreas Machens; Jeffrey F Moley; Furio Pacini; Friedhelm Raue; Karin Frank-Raue; Bruce Robinson; M Sara Rosenthal; Massimo Santoro; Martin Schlumberger; Manisha Shah; Steven G Waguespack
Journal:  Thyroid       Date:  2015-06       Impact factor: 6.568

4.  Adrenalectomy for familial pheochromocytoma in the laparoscopic era.

Authors:  L Michael Brunt; Terry C Lairmore; Gerard M Doherty; Mary A Quasebarth; Mary DeBenedetti; Jeffrey F Moley
Journal:  Ann Surg       Date:  2002-05       Impact factor: 12.969

5.  Improved results of cervical reoperation for medullary thyroid carcinoma.

Authors:  J F Moley; W G Dilley; M K DeBenedetti
Journal:  Ann Surg       Date:  1997-06       Impact factor: 12.969

Review 6.  Surgical strategy for the treatment of medullary thyroid carcinoma.

Authors:  J B Fleming; J E Lee; M Bouvet; P N Schultz; S I Sherman; R V Sellin; K E Friend; M A Burgess; G J Cote; R F Gagel; D B Evans
Journal:  Ann Surg       Date:  1999-11       Impact factor: 12.969

7.  The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer.

Authors:  Herbert Chen; Rebecca S Sippel; M Sue O'Dorisio; Aaron I Vinik; Ricardo V Lloyd; Karel Pacak
Journal:  Pancreas       Date:  2010-08       Impact factor: 3.327

Review 8.  Current understanding and management of medullary thyroid cancer.

Authors:  Madhuchhanda Roy; Herbert Chen; Rebecca S Sippel
Journal:  Oncologist       Date:  2013-09-13

9.  The value of 18F-DOPA PET-CT in patients with medullary thyroid carcinoma: comparison with 18F-FDG PET-CT.

Authors:  Mohsen Beheshti; Sigrid Pöcher; Reza Vali; Peter Waldenberger; Gabriele Broinger; Michael Nader; Susanne Kohlfürst; Christian Pirich; Henning Dralle; Werner Langsteger
Journal:  Eur Radiol       Date:  2009-01-21       Impact factor: 5.315

Review 10.  Evidence-based approach to the management of sporadic medullary thyroid carcinoma.

Authors:  Jeffrey F Moley; Elizabeth A Fialkowski
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.